Finally, although our dataset represents a relatively recent cohort for whom most of the contemporary adjuvant treatment options are provided, there are some novel therapeutic options that were not available, such as CDK4/6 inhibitors or pertuzumab.16,33 The implication of these recently developed therapeutic options in breast cancer with distant metastasis should be further explored in the future. The gene discussed is CDK4; the disease is breast cancer.